+ All Categories
Home > Documents > Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Date post: 23-Feb-2016
Category:
Upload: delora
View: 55 times
Download: 0 times
Share this document with a friend
Description:
Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance . Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^ * Utrecht University, The Netherlands ^ Radboud University Nijmegen, The Netherlands. - PowerPoint PPT Presentation
Popular Tags:
21
Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^ * Utrecht University, The Netherlands ^ Radboud University Nijmegen, The Netherlands
Transcript
Page 1: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Short-term efficacy of nicotine replacement therapy (NRT)

for smoking cessation among adolescents

and the role of compliance

Charlotte Scherphof*

Regina van den Eijnden*Wilma Vollebergh*Rutger Engels^

* Utrecht University, The Netherlands^ Radboud University Nijmegen, The Netherlands

Page 2: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^
Page 3: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Introduction• Nicotine dependence symptoms:

– 60.9% of adolescents who ever smoked cigarettes daily had tried to quit smoking, but…

• only 12.2% were successful.

• Nicotine Replacement Therapy (NRT) as smoking cessation intervention

Page 4: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Introduction

• Meta-analysis (2011): – 6 RCTs

• Review (2012): – 9 RCTs, 1 lab-based study, 3 open-label studies

• Results:– Short-term (end-of-treatment): /– Mid-term (3-6 months):

Page 5: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Introduction

• Flaws– Small sample sizes (9 of 11: N < 135)– High drop-out

– Low compliance (8-67%)• no moderation effects

condition smoking cessation

compliance

Page 6: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

(1) efficacy of NRT (nicotine patch) on short-term smoking cessation?

(2) is the effect of NRT on smoking cessation moderated by patch use compliance?

– 2a) can different trajectories of compliance be distinguished?– 2b) which factors predict different trajectories?

(3) are there any (serious) adverse effects?

Our study – Randomized Controlled Trial

Page 7: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

MethodAdolescents: N = 257, mean age 16.7 years, 53% female Information meeting 6/9 week treatment

6 online

questionnaires

1) Age 12 -18 years2) No major physical health problems 3) ≥ 7 cigarettes per day 4) Parents aware of kids smoking behaviour5) Motivated to quit smoking

€ 90

Page 8: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Outcome measures

• Smoking cessation (intent-to-treat)

– abstinence after two weeks / end-of-treatment abstinence (prolonged abstinence)

• Compliance– number of days participants used the patches

• Adverse events– complaints concerning health / patch use

Treatment period

T5T4 T6T1-T3Abstinence after 2 weeks

Week 1 Week 2 Week 3-6

End-of-treatment abstinence

Page 9: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

• Abstinence after two weeks

• End-of-treatment abstinence

Results – Main effect + Moderation

condition abstinence after 2 weeks

compliance

OR = 1.80*/2.02*

OR = 1.12/1.12

conditionOR = 0.83/0.79

abstinence at end of treatment

compliance

OR = 1.07†/1.09*

Page 10: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Results – Percentages quitters Abstinence after 2 weeks End-of-treatment abstinence

Placebo patch group 21.3% 13.1%Nicotine patch group 31.9% 14.8%

7 59 15

Page 11: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Compliance

Time

Com

plia

nce

Predictors

Page 12: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Results – Compliance trajectories (LCGA)

Predictors- Age- Gender- Education- #CigPerDay- Previous quit att. - Impulsivity- Conscientiousness- Openness- Extraversion- Neuroticsm- Agreeableness- Condition

Compliers: 34%Moderate decreasers: 16%Strong decreasers: 50%

23%

10%

9%

Page 13: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Results – adverse events

• Most reported adverse events

• In general more complaints in nicotine patch group (but scores max 2 out of 3)

Page 14: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Conclusion

(1) Nicotine patches enhance abstinence rates after two weeks.

(2) Nicotine patches enhance abstinence rates at end-of-treatment, but only among high-compliant adolescents.

(2a,b) Higher number of previous quit attempts, higher level of conscientiousness and lower levels of extraversion were associated with higher levels of compliance.

(3) No serious adverse events.Bgjsbel

Page 15: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Discussion

• Decline in compliance rates and abstinence rates from 2 weeks to end-of-treatment

– Clinical relevance?

• Comparison with previous studies (our study: 14.8% abstinence at end-treatment)– 18% (PA, 2-week grace period, 12 weeks of treatment)– 28% (7-day PP, 8 weeks of treatment)– 28% (7-day PP, 10 weeks of treatment)

• Time-varying predictors for compliance trajectories

Page 16: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Implications• So far, no convincing evidence of efficacy NRT for adolescents

• Interventions to enhance compliance

• Influence of (smoking) peers

Page 17: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^
Page 18: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

“Interventions aimed at quitting smoking among

adolescents are a waste of time (and money)”

Page 19: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Thank you for your attention

Charlotte [email protected]

Page 20: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Introduction

Percentage smoking adolescents (10-19 years) 1994-2011

boysgirls mean

Page 21: Charlotte Scherphof* Regina van den Eijnden* Wilma Vollebergh* Rutger Engels^

Model 1 Model 2

Step 1 Step 2 Step 1 Step2

OR OR OR OR

Abstinence after 2 weeks

Condition 1.80* 0.39 2.02* 0.49

Gender 0.76 0.71 0.65 0.62

Compliance 1.35** 1.33*

Compliance x Condition 1.12 1.12

Self-efficacy 1.50* 1.37

Alcohol consumption 0.96 0.96

Drug use 0.97** 0.97**

End-of-treatment abstinence

Condition 0.83 0.13 0.79 0.08*

Gender 0.60 0.63 0.51 0.54

2-week abstinence 15.84*** 15.06*** 14.84*** 15.04***

Compliance 0.98 0.97

Compliance x Condition 1.07† 1.09*

Self-efficacy 1.86* 1.94*

Alcohol consumption 0.92† 0.91*

Drug use 1.01 1.01

Results - Short-term effects

Condition Smoking cessation

Compliance

Condition Smoking cessation

Compliance


Recommended